GRI logo

GRIGRI Bio Inc

$2.30
$0.06
(2.60%)
Today
Closed $2.25
$0.0481
(2.14%)
After Hours
Updated: 07:28 PM EDT
Mkt Cap$4.09M
Vol51,046.00
News
all
press releases
News Placeholder
GRI Bio Reports Positive Study Results For Chronic Lung Disease, But Stock Slumps 20% — What Happened?
The company said that the new data indicate that GRI-0621 may support the regeneration of lung tissue.
Stocktwits
News Placeholder
GRI Bio Drug Shows Promising Lung Function Recovery In Patients With Thickened Lungs
GRI Bio shared promising data from a Phase 2a trial for idiopathic pulmonary fibrosis, a chronic lung disease with no known cause.read more...
Benzinga
News Placeholder
Barclays lifts Kojamo, I-RES ratings; cuts Grainger on low yield
investing.com
<
...
1
>

Advertisement|Remove ads.